Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer
- 31 October 1990
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 6 (3-4) , 87-98
- https://doi.org/10.1016/0169-5002(90)90112-y
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective studyCancer, 1989
- Combination Chemotherapy with Methotrexate, Adriamycin, Cyclophosphamide and CCNU (MACC) for Nonsmall Cell Lung CancerOncology, 1989
- Antibody-guided diagnosis: An italian experience on cea-expressing tumoursInternational Journal of Cancer, 1988
- Is there standard chemotherapy for non-small cell lung cancer?European Journal of Cancer and Clinical Oncology, 1986
- Chemotherapy in non-small cell bronchial carcinoma.Thorax, 1985
- Progress in chemotherapy of non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung.Low response rate in a cooperative group studyCancer, 1979
- MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancerCancer, 1979
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Methotrexate compared with placebo in lung cancerCancer, 1977